Trial Profile
A Phase 2, Randomized, Controlled, Multicenter, Evaluation of the Efficacy and Safety of Locally Administered HTX-011, HTX-002, or HTX-009 for Postoperative Analgesia Following Bunionectomy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2023
Price :
$35
*
At a glance
- Drugs Bupivacaine/meloxicam (Primary) ; Bupivacaine/meloxicam (Primary) ; Bupivacaine
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Heron Therapeutics
- 13 Sep 2023 Number of treatment arms have been decreased from 27 to 11.
- 26 Sep 2017 Status changed from active, no longer recruiting to completed.
- 31 Mar 2017 Planned End Date changed from 1 Mar 2017 to 1 Apr 2017.